These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 7529301)

  • 21. The role of endothelin-1 in the origin of cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage.
    Suzuki R; Masaoka H; Hirata Y; Marumo F; Isotani E; Hirakawa K
    J Neurosurg; 1992 Jul; 77(1):96-100. PubMed ID: 1607979
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The maximum safe dosage of the low molecular weight hydroxyethyl starch, HESPANDAR (HES), estimated from HES induced changes in coagulation parameters and clinical bleeding].
    Saito Y; Uchida K; Yamamoto H; Ichiishi N; Matsushita F
    Masui; 1999 Mar; 48(3):238-43. PubMed ID: 10214006
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Platelet inhibitors and hydroxyethyl starch: safe and cost-effective interventions in coronary artery surgery.
    Hicks GL; Jensen LA; Norsen LH; Quinn JR; Stewart SS; DeWeese JA
    Ann Thorac Surg; 1985 May; 39(5):422-5. PubMed ID: 2581521
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hetastarch in perioperative volume expansion.
    Alexander JC
    Chest; 2003 Oct; 124(4):1194-6. PubMed ID: 14555545
    [No Abstract]   [Full Text] [Related]  

  • 25. Nimodipine for cerebral vasospasm after subarachnoid hemorrhage.
    Med Lett Drugs Ther; 1989 May; 31(792):47-8. PubMed ID: 2654592
    [No Abstract]   [Full Text] [Related]  

  • 26. Testing of blood products in a polytrauma model: results of a multi-institutional randomized preclinical trial.
    Alam HB; Bice LM; Butt MU; Cho SD; Dubick MA; Duggan M; Englehart MS; Holcomb JB; Morris MS; Prince MD; Schreiber MA; Shults C; Sondeen JL; Tabbara M; Tieu BH; Underwood SA;
    J Trauma; 2009 Oct; 67(4):856-64. PubMed ID: 19820596
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The experiences of a large amount of steroid therapy for symptomatic vasospasm after subarachnoid hemorrhage: clinical analysis of 21 cases].
    Yasukawa K; Kamijou Y; Momose G; Kobayashi S; Kuroyanagi T; Morota N; Unoki T
    No Shinkei Geka; 1994 Jan; 22(1):17-22. PubMed ID: 8295697
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Calcium antagonists in the management of patients with aneurysmal subarachnoid hemorrhage: a review.
    Adams HP
    Angiology; 1990 Nov; 41(11 Pt 2):1010-6. PubMed ID: 2248423
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of nizofenone on the symptomatic vasospasm after aneurysmal subarachnoid hemorrhage and its relationship to the levels of serum complements (CH50, C3 and C4)].
    Ogata N; Yonekawa Y; Kawano T; Tsukahara T
    Nihon Geka Hokan; 1991 Mar; 60(2):135-9. PubMed ID: 1819244
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Volume replacement therapy during hip arthroplasty using hydroxyethyl starch (130/0.4) compared to lactated Ringer decreases allogeneic blood transfusion and postoperative infection.
    Hamaji A; Hajjar L; Caiero M; Almeida J; Nakamura RE; Osawa EA; Fukushima J; Galas FR; Auler JO
    Braz J Anesthesiol; 2013 Jan; 63(1):27-35. PubMed ID: 24565088
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disseminated intravascular coagulation due to intravenous administration of hetastarch.
    Chang JC; Gross HM; Jang NS
    Am J Med Sci; 1990 Nov; 300(5):301-3. PubMed ID: 1700605
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Coagulation abnormalities in stroke--disseminated intravascular coagulation as a complication of subarachnoid hemorrhage].
    Fujita K; Tamaki N
    Rinsho Byori; 1991 Jul; 39(7):729-35. PubMed ID: 1920866
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The use of hetastarch as adjunct therapy in 26 dogs with hypoalbuminemia: a phase two clinical trial.
    Smiley LE; Garvey MS
    J Vet Intern Med; 1994; 8(3):195-202. PubMed ID: 7520494
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coagulopathy induced by colloid plasma expanders--search for an efficacious haemostatic intervention.
    Fenger-Eriksen C; Ingerslev J; Sørensen B
    Acta Anaesthesiol Scand; 2006 Aug; 50(7):899-900. PubMed ID: 16879481
    [No Abstract]   [Full Text] [Related]  

  • 35. Predictable reduction of intracranial hypertension with hypertonic saline hydroxyethyl starch: a prospective clinical trial in critically ill patients with subarachnoid haemorrhage.
    Bentsen G; Breivik H; Lundar T; Stubhaug A
    Acta Anaesthesiol Scand; 2004 Oct; 48(9):1089-95. PubMed ID: 15352953
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Hyponatremia and cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage].
    Morinaga K; Hayashi S; Matsumoto Y; Omiya N; Mikami J; Ueda M; Sato H; Inoue Y; Okawara S
    No To Shinkei; 1992 Jul; 44(7):629-32. PubMed ID: 1419338
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hetastarch complication.
    Spitzer DE
    J Neurosurg; 1995 Aug; 83(2):382. PubMed ID: 7542318
    [No Abstract]   [Full Text] [Related]  

  • 38. [Management using nimodipine of cerebral vasospasm secondary to subarachnoid hemorrhage caused by rupture of an intracranial aneurysm].
    Maldonado JA; Milchorena G; López-Camacho O; Madrazo I
    Arch Invest Med (Mex); 1990; 21(2):179-87. PubMed ID: 2103708
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Advanced concepts in the management of cerebral vasospasm associated with aneurysmal subarachnoid hemorrhage.
    Warnell P
    Axone; 1996 Jun; 17(4):86-92. PubMed ID: 8716943
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Preliminary clinical trial of intrathecal rt-PA (TD-2061) for the prevention of cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage].
    Sasaki T; Ohta T; Kikuch H; Takakura K; Usui M; Kondoh A; Tanabe H; Nakamura J; Yamada K
    No To Shinkei; 1992 Nov; 44(11):1001-8. PubMed ID: 1296711
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.